UTSW scientists identify brain circuit that triggers rare, blood sugar-dependent epilepsy

A small group of brain cells linked in a circuit is responsible for setting off whole-brain seizures in a rare form of epilepsy affected by blood sugar levels, a study led by UT Southwestern researchers suggests. The finding, published in Science Translational Medicine, could lead to new treatments for other metabolic disorders in the brain, the authors said.

UCI’s Oswald Steward to serve as president of Society for Neuroscience

Irvine, Calif., Nov. 15, 2022 — The University of California, Irvine today announced that Oswald Steward, director of the campus’s Reeve-Irvine Research Center, will assume the role of president of the Society for Neuroscience, the world’s largest organization for the study of the brain and nervous system, with more than 36,000 members in 95 countries.

Brain-gut connection may reveal way to prevent cocaine addiction

Cocaine disrupts the balance of microbes in the guts of mice, part of a cycle of waxing and waning neurochemicals that can enhance the drug’s effects in the brain. But the same chemicals may also be harnessed to prevent addiction, according to new research from the University of Wisconsin–Madison.Cocaine increases levels of a hormone called norepinephrine in users’ intestines, triggering an explosion of growth of proteobacteria, a family of microbes that includes the common and sometimes harmful bacterium E.

Addressing Health Inequities Could Help Avert a Neurologic Health Crisis

The closing plenary session at ANA2022 spotlighted neurologic health inequities and presented new research finding that neighborhood disadvantage strongly predicted likelihood of death from neurologic conditions independent of individual wealth and demographics.

Today: ANA2022 Media Roundtable to Spotlight Latest in Neuro Research

As the American Neurological Association’s 147th Annual Meeting wraps up today, October 25, the ANA is holding a Media Roundtable at 11 a.m. U.S. Central for reporters to access the latest developments in neurology and neuroscience.

An Environmental Wake-Up Call for Neurology

The Presidential Symposium at the American Neurological Association’s 2022 Annual Meeting (ANA2022) in Chicago will shine a spotlight on the role of environmental exposures — air pollution, pesticides, microplastics, and more — in diseases like dementias and developmental disorders.

American Neurological Association Publishes Research Abstracts for ANA2022, Oct. 22–25 in Chicago

Abstracts of breaking research in neurology and neuroscience, to be presented at the 2022 American Neurological Association Annual Meeting Oct. 22-25, are now available in Annals of Neurology and on the ANA2022 website.

Dr. Jaideep Bains to join UHN as new Director of the Krembil Research Institute

(Toronto, Oct. 3, 2022) – University Health Network (UHN) is pleased to announce that Dr. Jaideep Bains will be joining our team as the new Director of the Krembil Research Institute. The Krembil Research Institute, one of the principal institutes within UHN, comprises the Krembil Brain Institute, the Schroeder Arthritis Institute and the Donald K.

University of Washington joins industry-academia alliance to accelerate research in neuroscience

The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between UC San Francisco, UC Berkeley, Genentech (a member of the Roche group) and Roche Holding AG geared to transform the fight against brain diseases and disorders of the central nervous system.

FAU, Israel Scientists ‘Team Up’ to Tackle Alzheimer’s-related Mood Disorders

Researchers from Florida Atlantic University, in collaboration with Tel Aviv University, have received a two-year, $379,177 grant from the National Institute on Aging, National Institutes for Health, on a collaborative project to study mood-disorders changes in Alzheimer’s disease.

Multiple sclerosis drug works in a surprising way

Drugs called interferon betas are common treatments for multiple sclerosis. Interferon beta, a protein known to contain a zinc-binding pocket, is thought to reduce proinflammatory molecules in MS patients. But researchers now report in ACS Chemical Neuroscience that the molecule reduces the binding of three components — zinc, C-peptide and albumin — to red blood cells.

Binghamton University, Upstate Medical agree to closer collaborations

A new agreement between Upstate Medical University and Binghamton University’s Thomas J. Watson College of Engineering and Applied Science will strengthen ties between the two schools and encourage closer research collaborations.

MD Anderson to host virtual Cancer Neuroscience Symposium

MD Anderson will host the virtual Cancer Neuroscience Symposium Sept. 22-23, 2022, in collaboration with the journal Advanced Biology. The symposium is free to attend and gathers leading experts in the field to discuss a variety of topics on the relationship between cancer biology and neuroscience. Registration includes the opportunity to participate in an abstract competition and to view sessions following the event.

Ochsner Health Receives $700K Dementia Care Grant from the National Institute on Aging and National Institutes of Health

The National Institute on Aging (NIA) and the National Institutes of Health (NIH) awarded Ochsner Health a $700,000 grant to study the effectiveness of its collaborative dementia care through the Ochsner Neuroscience Institute’s Brain Health and Cognitive Disorders Program.

People respond differently to psychedelic drugs — genetics could be the reason

Psychedelic drugs have shown benefits as treatments for cluster headaches, anxiety and depression in clinical studies, but not for everyone. Now, in ACS Chemical Neuroscience, researchers report that one reason could be common genetic variations in one serotonin receptor.